Clinical Trial: Ondansetron for the Treatment of Methamphetamine Dependence - 1

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: Double-Blind, Placebo-Controlled, Dose Response Trial of Ondansetron for the Treatment of Methamphetamine Dependence.

Brief Summary: The purpose of this study is to assess ondansetron for the treatment of methamphetamine dependence.

Detailed Summary: This study was designed to be a preliminary assessment of the efficacy and safety of 3-wide range doses of ondansetron (0.25, 1.0 and 4.0 mg taken orally twice per day) to reduce methamphetamine use in subjects with methamphetamine dependence and to determine the optimal dose of ondansetron.
Sponsor: National Institute on Drug Abuse (NIDA)

Current Primary Outcome: Clinicial improvement

Original Primary Outcome: Same as current

Current Secondary Outcome:

Original Secondary Outcome:

Information By: National Institute on Drug Abuse (NIDA)

Dates:
Date Received: June 18, 2002
Date Started: June 2002
Date Completion:
Last Updated: January 11, 2017
Last Verified: July 2008